Previous 10 |
home / stock / tdsgf / tdsgf news
TORONTO, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Telo Genomics Corp. (TSX-V: TELO) (the “Company” or “TELO”) is pleased to announce that it has launched a commercial evaluation in collaboration with Applied Spectral Imaging (ASI) California to assess the applica...
TORONTO, Dec. 20, 2019 (GLOBE NEWSWIRE) -- Telo Genomics Corp. (TSX-V: TELO) (the “ Company ” or “ TELO ”), is pleased to announce that it has signed a collaboration agreement with Mayo Clinic in Minnesota to conduct clinical studies to eval...
TORONTO, Nov. 28, 2019 (GLOBE NEWSWIRE) -- Telo Genomics Corp. (TSX-V: TELO) (the “ Company ” or “ TELO ”) announces that it has granted incentive stock options to various directors, officers, employees and consultants of the Company to purchase up to an aggreg...
TORONTO, Nov. 25, 2019 (GLOBE NEWSWIRE) -- Telo Genomics Corp. (TSX-V: TELO) (the “ Company ” or “ TELO ”) is pleased to announce that it has closed its previously announced oversubscribed $1,735,500 non-brokered private placement and $1,054,885 debt settlement...
3D Signatures ( OTCPK:TDSGF ) announced that it has changed its corporate name to Telo Genomics and it's common shares will commence trading on the TSX Venture Exchange. More news on: 3D Signatures Inc, Read more ...
TORONTO, April 08, 2019 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V: DXD) (the “Company” or “3DS”) is pleased to announce that it has changed its corporate name to Telo Genomics Corp . effective April 08, 2019. Effective at the opening of trading on April 08, ...
News, Short Squeeze, Breakout and More Instantly...
Teledata Singapore Ltd Company Name:
TDSGF Stock Symbol:
OTCMKTS Market:
Teledata Singapore Ltd Website:
Toronto, Ontario--(Newsfile Corp. - June 18, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) ( the "Company" or "Telo") a biotech company developing the industry's leading telomere technology platform with diagnostic and prognostic applications measuring genomic instability in oncolo...
Toronto, Ontario--(Newsfile Corp. - June 12, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3D0A) ("Telo" or the "Company"), is pleased to announce that results of the development, validation and implementation of its machine learning and Artificial Intelligence (AI) modules, u...
Toronto, Ontario--(Newsfile Corp. - May 30, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3DOA), ( the "Company" or "Telo"), a biotech company developing the industry's leading telomere technology platform with diagnostic and prognostic applications in oncology, is thrilled t...